IL145502A0 - Transdermal therapeutic system with nicotine and addition of monoterpene ketones - Google Patents

Transdermal therapeutic system with nicotine and addition of monoterpene ketones

Info

Publication number
IL145502A0
IL145502A0 IL14550200A IL14550200A IL145502A0 IL 145502 A0 IL145502 A0 IL 145502A0 IL 14550200 A IL14550200 A IL 14550200A IL 14550200 A IL14550200 A IL 14550200A IL 145502 A0 IL145502 A0 IL 145502A0
Authority
IL
Israel
Prior art keywords
nicotine
addition
therapeutic system
transdermal therapeutic
monoterpene ketones
Prior art date
Application number
IL14550200A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL145502A0 publication Critical patent/IL145502A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14550200A 1999-03-26 2000-03-21 Transdermal therapeutic system with nicotine and addition of monoterpene ketones IL145502A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913732A DE19913732A1 (de) 1999-03-26 1999-03-26 Nikotin-TTS mit einem Zusatz von Monoterpenketonen
PCT/EP2000/002457 WO2000057824A1 (de) 1999-03-26 2000-03-21 Nikotin-tts mit einem zusatz von monoterpenketonen

Publications (1)

Publication Number Publication Date
IL145502A0 true IL145502A0 (en) 2002-06-30

Family

ID=7902491

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14550200A IL145502A0 (en) 1999-03-26 2000-03-21 Transdermal therapeutic system with nicotine and addition of monoterpene ketones

Country Status (23)

Country Link
US (1) US7029692B1 (hu)
EP (1) EP1164996B1 (hu)
JP (1) JP4750282B2 (hu)
KR (1) KR100597802B1 (hu)
CN (1) CN1199623C (hu)
AR (1) AR027485A1 (hu)
AT (1) ATE252356T1 (hu)
AU (1) AU769656B2 (hu)
BR (1) BR0010515A (hu)
CA (1) CA2367615C (hu)
CZ (1) CZ300409B6 (hu)
DE (2) DE19913732A1 (hu)
DK (1) DK1164996T3 (hu)
ES (1) ES2211523T3 (hu)
HU (1) HUP0200189A3 (hu)
IL (1) IL145502A0 (hu)
NZ (1) NZ514423A (hu)
PT (1) PT1164996E (hu)
RU (1) RU2228740C2 (hu)
TR (1) TR200102605T2 (hu)
TW (1) TWI227666B (hu)
WO (1) WO2000057824A1 (hu)
ZA (1) ZA200107864B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
AR030312A1 (es) * 2000-08-03 2003-08-20 Antares Pharma Ipl Ag Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
ES2377932T3 (es) * 2003-10-10 2012-04-03 Ferring Bv Formulación farmacéutica transdérmica para minimizar los residuos sobre la piel
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US8067399B2 (en) * 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
ES2499067T3 (es) * 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
CN101264277B (zh) * 2008-04-16 2012-09-26 冯冲 一种控烟戒烟复方精油
EP2552245B1 (en) * 2010-03-26 2018-11-14 Philip Morris Products S.A. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
JP6888974B2 (ja) * 2016-01-27 2021-06-18 学校法人近畿大学 Ｃｙｐ２ａ１３阻害活性を有する化合物及びｃｙｐ２ａ１３阻害剤
US20190083527A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Method of administration and treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559655A (en) * 1969-02-25 1971-02-02 Sutton Res Corp Oxidized cellulose substitute smoking material and method of making same
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH01157921A (ja) * 1987-12-15 1989-06-21 Tsumura & Co 二重盲検試験用製剤の製造方法
JPH01290608A (ja) * 1988-05-18 1989-11-22 Sunstar Inc 殺菌剤組成物
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
JPH0748190B2 (ja) * 1990-01-22 1995-05-24 株式会社東芝 キャッシュメモリ内蔵マイクロプロセッサ
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
JPH06181972A (ja) * 1992-12-18 1994-07-05 Kanebo Ltd 煙草臭消臭剤
US5520924A (en) * 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JPH07133490A (ja) * 1993-11-10 1995-05-23 Pola Chem Ind Inc 消臭剤
AU2703795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
JPH09110680A (ja) * 1995-10-19 1997-04-28 Yuutoku Yakuhin Kogyo Kk 皮膚炎治療貼付剤
JPH10130118A (ja) * 1996-10-25 1998-05-19 Lion Corp 外用剤組成物
JPH10306030A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd 外用剤組成物

Also Published As

Publication number Publication date
CN1199623C (zh) 2005-05-04
HUP0200189A2 (hu) 2002-05-29
TWI227666B (en) 2005-02-11
AR027485A1 (es) 2003-04-02
PL351313A1 (en) 2003-04-07
US7029692B1 (en) 2006-04-18
CZ20013457A3 (cs) 2002-03-13
WO2000057824A1 (de) 2000-10-05
HUP0200189A3 (en) 2011-02-28
CA2367615A1 (en) 2000-10-05
CZ300409B6 (cs) 2009-05-13
AU769656B2 (en) 2004-01-29
AU3813400A (en) 2000-10-16
CN1345213A (zh) 2002-04-17
JP4750282B2 (ja) 2011-08-17
EP1164996B1 (de) 2003-10-22
KR20010112366A (ko) 2001-12-20
ATE252356T1 (de) 2003-11-15
RU2228740C2 (ru) 2004-05-20
ZA200107864B (en) 2002-11-27
CA2367615C (en) 2009-10-13
EP1164996A1 (de) 2002-01-02
JP2002540125A (ja) 2002-11-26
ES2211523T3 (es) 2004-07-16
NZ514423A (en) 2003-08-29
TR200102605T2 (tr) 2002-01-21
PT1164996E (pt) 2004-03-31
KR100597802B1 (ko) 2006-07-10
DK1164996T3 (da) 2004-02-16
BR0010515A (pt) 2003-07-22
DE50004156D1 (de) 2003-11-27
DE19913732A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
IL145502A0 (en) Transdermal therapeutic system with nicotine and addition of monoterpene ketones
AU1781901A (en) Expandable venous cannula and method of use
HUP0203563A3 (en) Fungicidal combinations of active substances and use thereof
EP1227821A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF
EP1231864A4 (en) Tissue-Attachable Drug Applicator and Method of Use Thereof
EP1047431A4 (en) PHARMACEUTICALLY ACTIVE CONNECTIONS AND METHOD FOR THE USE THEREOF
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
EP1154997A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
AP2002002393A0 (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
MXPA02000779A (es) Factor de activacion de la citocina altamente purificada y metodos de uso.
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
HUP0201966A3 (en) Methods of treatment and drug screening methods
AU3501700A (en) Human endokine alpha and methods of use
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
AU2566201A (en) Compounds and methods for the treatment of pain
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
EP1322274A4 (en) LOCAL THERAPEUTIC SOLUTION FOR SKIN, AND METHODS OF USE
HK1044568A1 (zh) 一種治療劑的應激應答性誘導及其使用方法
AU2420201A (en) Compounds and methods for the treatment of pain
GB9905307D0 (en) Therapy and use of compounds in therapy
GB9905315D0 (en) Therapy and use of compounds in therapy
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
EP1210111A4 (en) DNA OF GAMMA HERPESVIRUS AND METHODS OF USE THEREOF
IL153452A0 (en) Treatment and prevention of cardiac insulin resistance associated conditions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired